1. Home
  2. NVCT vs AIP Comparison

NVCT vs AIP Comparison

Compare NVCT & AIP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NVCT
  • AIP
  • Stock Information
  • Founded
  • NVCT 2020
  • AIP 2003
  • Country
  • NVCT United States
  • AIP United States
  • Employees
  • NVCT N/A
  • AIP N/A
  • Industry
  • NVCT Medicinal Chemicals and Botanical Products
  • AIP Semiconductors
  • Sector
  • NVCT Health Care
  • AIP Technology
  • Exchange
  • NVCT Nasdaq
  • AIP Nasdaq
  • Market Cap
  • NVCT 249.1M
  • AIP 276.6M
  • IPO Year
  • NVCT 2022
  • AIP 2021
  • Fundamental
  • Price
  • NVCT $8.98
  • AIP $7.65
  • Analyst Decision
  • NVCT Strong Buy
  • AIP Strong Buy
  • Analyst Count
  • NVCT 3
  • AIP 3
  • Target Price
  • NVCT $17.00
  • AIP $15.00
  • AVG Volume (30 Days)
  • NVCT 132.1K
  • AIP 268.0K
  • Earning Date
  • NVCT 05-06-2025
  • AIP 05-13-2025
  • Dividend Yield
  • NVCT N/A
  • AIP N/A
  • EPS Growth
  • NVCT N/A
  • AIP N/A
  • EPS
  • NVCT N/A
  • AIP N/A
  • Revenue
  • NVCT N/A
  • AIP $61,309,000.00
  • Revenue This Year
  • NVCT N/A
  • AIP $19.82
  • Revenue Next Year
  • NVCT N/A
  • AIP $17.29
  • P/E Ratio
  • NVCT N/A
  • AIP N/A
  • Revenue Growth
  • NVCT N/A
  • AIP 14.68
  • 52 Week Low
  • NVCT $4.44
  • AIP $5.46
  • 52 Week High
  • NVCT $11.80
  • AIP $12.64
  • Technical
  • Relative Strength Index (RSI)
  • NVCT 44.39
  • AIP 56.15
  • Support Level
  • NVCT $9.92
  • AIP $7.53
  • Resistance Level
  • NVCT $11.15
  • AIP $8.11
  • Average True Range (ATR)
  • NVCT 0.64
  • AIP 0.48
  • MACD
  • NVCT -0.09
  • AIP 0.02
  • Stochastic Oscillator
  • NVCT 26.94
  • AIP 48.80

About NVCT Nuvectis Pharma Inc.

Nuvectis Pharma Inc is a biopharmaceutical company. The company is engaged in the development of innovative precision medicines for the treatment of serious conditions of unmet medical needs in oncology. It operates with one segment, focused on the development of novel targeted small molecule therapeutics for the treatment of cancer in genetically defined patient populations. Its pipeline products include NXP800, NXP900.

About AIP Arteris Inc.

Arteris Inc is a provider of semiconductor system IP, including interconnect and other intellectual property, (collectively, System IP) technology. Its IP technology manages the on-chip communications and IP block deployments in System-on-Chip (SoC) semiconductors and systems of chiplets. Its proprietary System IP solutions achieve this by connecting client IP blocks such as processors, memories, artificial intelligence/machine learning (AI/ML) accelerators, graphics subsystems, safety and security, and other input/output subsystems (I/Os) via multiple Network-on-Chips (NoCs). The company operates in Americas, Asia Pacific and Europe, Middle East, out of which it derives maximum profit from Asia Pacific.

Share on Social Networks: